Neurotensin: An endogenous antipsychotic? Commentary

Becky Kinkead, Charles B. Nemeroff

Research output: Contribution to journalComment/debatepeer-review

51 Scopus citations


Despite evidence from a variety of experimental approaches implicating the neuropeptide neurotensin in both the mechanism of action of antipsychotic drugs and the pathophysiology of schizophrenia, there has been some debate as to whether a peripherally administered neurotensin receptor agonist represents a sound strategy for the development of a novel class of antipsychotic drugs.

Original languageEnglish (US)
Pages (from-to)99-103
Number of pages5
JournalCurrent Opinion in Pharmacology
Issue number1
StatePublished - Feb 1 2002
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Neurotensin: An endogenous antipsychotic? Commentary'. Together they form a unique fingerprint.

Cite this